Chitosan–xanthan gum microparticle-based oral tablet for colon-targeted and sustained delivery of quercetin

Abstract Context: Quercetin (QUE) is a flavonoid with antioxidant/anti-inflammatory properties, poorly absorbed when orally administered. Objectives: To prepare chitosan/xanthan gum microparticles to increase QUE oral bioavailability and optimize its release in the colon. Materials and methods: Chitosan/xanthan gum hydrogel embedding QUE was spray-dried to obtain microparticles characterized by size, scanning electron microscopy, differential scanning calorimetry and X-ray diffraction. Microparticles were compressed into tablets, coated with Eudragit® to further prevent degradation in acidic pH. The swelling degree and QUE release in simulated gastric and intestinal pH were investigated. Results: Microparticles were smooth and spherical, around 5 µm, with successful QUE loading. Microparticle tablets provided resistance to acidic conditions, allowing complete drug release in alkaline pH, mimicking colonic environment. The release was controlled by non-Fickian diffusion of the dissolved drug out of the swollen polymeric tablet. Discussion and conclusion: Microparticle tablets represent a promising dosage form for QUE delivery to the colon in the oral therapy of inflammatory-based disorders.

[1]  Hua Zheng,et al.  Preparation of dual crosslinked alginate-chitosan blend gel beads and in vitro controlled release in oral site-specific drug delivery system. , 2007, International journal of pharmaceutics.

[2]  J. Kristl,et al.  Improvements of cellular stress response on resveratrol in liposomes. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[3]  A. Fadda,et al.  Liposomes as Carriers for Verbascoside: Stability and Skin Permeation Studies , 2008 .

[4]  A. Domb,et al.  Chitosan chemistry and pharmaceutical perspectives. , 2004, Chemical reviews.

[5]  H. Jain,et al.  Colon-targeted quercetin delivery using natural polymer to enhance its bioavailability , 2011, Pharmacognosy research.

[6]  I. Rashid,et al.  Bioadhesive Controlled Metronidazole Release Matrix Based on Chitosan and Xanthan Gum , 2010, Marine drugs.

[7]  O.N.M. Mc Callion,et al.  The influence of surface tension on aerosols produced by medical nebulisers , 1996 .

[8]  J. Czernuszka,et al.  Encapsulation and release of a hydrophobic drug from hydroxyapatite coated liposomes. , 2007, Biomaterials.

[9]  V. Shah,et al.  Steps for Development of a Dissolution Test for Sparingly Water-Soluble Drug Products , 2000 .

[10]  A. Bast,et al.  Health effects of quercetin: from antioxidant to nutraceutical. , 2008, European journal of pharmacology.

[11]  A. Fadda,et al.  Effect of Penetration Enhancer Containing Vesicles on the Percutaneous Delivery of Quercetin through New Born Pig Skin , 2011, Pharmaceutics.

[12]  A. Basit,et al.  Encapsulation of poorly soluble basic drugs into enteric microparticles: a novel approach to enhance their oral bioavailability. , 2011, International journal of pharmaceutics.

[13]  A. Casanovas,et al.  Chitosomes as drug delivery systems for C-phycocyanin: preparation and characterization. , 2010, International journal of pharmaceutics.

[14]  João F Pinto,et al.  Site-specific drug delivery systems within the gastro-intestinal tract: from the mouth to the colon. , 2010, International journal of pharmaceutics.

[15]  A. Fadda,et al.  Nanocarriers for antioxidant resveratrol: formulation approach, vesicle self-assembly and stability evaluation. , 2013, Colloids and surfaces. B, Biointerfaces.

[16]  A. Fadda,et al.  Design, characterization and in vitro evaluation of 5-aminosalicylic acid loaded N-succinyl-chitosan microparticles for colon specific delivery. , 2012, Colloids and surfaces. B, Biointerfaces.

[17]  Liliana Jiménez,et al.  Polyphenols: food sources and bioavailability. , 2004, The American journal of clinical nutrition.

[18]  N. Peppas,et al.  Mechanisms of solute release from porous hydrophilic polymers , 1983 .

[19]  R. Pons,et al.  Topical Anti-Inflammatory Potential of Quercetin in Lipid-Based Nanosystems: In Vivo and In Vitro Evaluation , 2013, Pharmaceutical Research.

[20]  N A Peppas,et al.  Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). , 2001, Advanced drug delivery reviews.

[21]  B. Shan,et al.  Quercetin Inhibit Human SW480 Colon Cancer Growth in Association with Inhibition of Cyclin D1 and Survivin Expression through Wnt/β-Catenin Signaling Pathway , 2009, Cancer investigation.

[22]  J. Kristl,et al.  Effect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cells. , 2008, International journal of pharmaceutics.

[23]  T. Ravi,et al.  Role of Surfactant and pH in Dissolution of Curcumin , 2009, Indian journal of pharmaceutical sciences.